WallStreetZenWallStreetZen

NASDAQ: NSTG
Nanostring Technologies Inc Stock Forecast, Predictions & Price Target

Analyst price target for NSTG

Based on 5 analysts offering 12 month price targets for Nanostring Technologies Inc.
Min Forecast
$14.00+61.85%
Avg Forecast
$21.20+145.09%
Max Forecast
$37.00+327.75%

Should I buy or sell NSTG stock?

Based on 5 analysts offering ratings for Nanostring Technologies Inc.
Buy
Strong Buy
2 analysts 40%
Buy
2 analysts 40%
Hold
1 analysts 20%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their NSTG stock forecasts and price targets.

NSTG stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Morgan Stanley
Bottom 9%
9
HoldMaintains$16.00+84.97%2023-03-02
UBS
Bottom 17%
17
Strong BuyInitiates Coverage On$15.00+73.41%2023-02-02
Cowen & Co.
Top 12%
89
BuyMaintains$24.00+177.46%2022-11-08
Baird
Bottom 21%
21
BuyMaintains$14.00+61.85%2022-11-08

1 of 1

Forecast return on equity

Is NSTG forecast to generate an efficient return?
Company
-131.75%
Industry
2.39%
Market
51.53%
NSTG's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is NSTG forecast to generate an efficient return on assets?
Company
-17.08%
Industry
4.29%
NSTG is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

NSTG earnings per share forecast

What is NSTG's earnings per share in the next 2 years based on estimates from 3 analysts?
Avg 1 year Forecast
-$1.92
Avg 2 year Forecast
-$1.29

NSTG revenue forecast

What is NSTG's revenue in the next 2 years based on estimates from 3 analysts?
Avg 1 year Forecast
$213.8M+67.98%
Avg 2 year Forecast
$267.2M+109.99%
NSTG's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

NSTG revenue growth forecast

How is NSTG forecast to perform vs Biotechnology companies and vs the US market?
Company
67.98%
Industry
243.21%
Market
25.31%
NSTG's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
NSTG's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

NSTG vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
NSTG$8.65$21.20+145.09%Buy
SRRK$7.81$24.20+209.86%Strong Buy
CMPX$3.18$9.38+195.06%Strong Buy
MESO$3.09$10.83+250.58%Buy
RPTX$9.70$20.00+106.19%Buy

Nanostring Technologies Stock Forecast FAQ

Is Nanostring Technologies Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 5 Wall Street analysts covering (NASDAQ: NSTG) stock is to Buy NSTG stock.

Out of 5 analysts, 2 (40%) are recommending NSTG as a Strong Buy, 2 (40%) are recommending NSTG as a Buy, 1 (20%) are recommending NSTG as a Hold, 0 (0%) are recommending NSTG as a Sell, and 0 (0%) are recommending NSTG as a Strong Sell.

If you're new to stock investing, here's how to buy Nanostring Technologies stock.

What is NSTG's earnings growth forecast for 2023-2024?

(NASDAQ: NSTG) Nanostring Technologies's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 74.79%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 77.85%.

Nanostring Technologies's earnings in 2023 is -$159,543,000.On average, 3 Wall Street analysts forecast NSTG's earnings for 2023 to be -$89,838,772, with the lowest NSTG earnings forecast at -$95,921,605, and the highest NSTG earnings forecast at -$85,159,669.

In 2024, NSTG is forecast to generate -$60,360,425 in earnings, with the lowest earnings forecast at -$60,360,425 and the highest earnings forecast at -$60,360,425.

What is NSTG's revenue growth forecast for 2023-2024?

(NASDAQ: NSTG) Nanostring Technologies's forecast annual revenue growth rate of 67.98% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 243.21%, and while it is forecast to beat the US market's average forecast revenue growth rate of 25.31%.

Nanostring Technologies's revenue in 2023 is $127,262,000.On average, 3 Wall Street analysts forecast NSTG's revenue for 2023 to be $10,002,845,379, with the lowest NSTG revenue forecast at $9,244,971,115, and the highest NSTG revenue forecast at $10,532,660,178.

In 2024, NSTG is forecast to generate $12,504,246,891 in revenue, with the lowest revenue forecast at $11,469,884,449 and the highest revenue forecast at $13,538,656,125.

What is NSTG's forecast return on assets (ROA) for 2023-2024?

(NASDAQ: NSTG) forecast ROA is -17.08%, which is lower than the forecast US Biotechnology industry average of 4.29%.

What is NSTG's Price Target?

According to 5 Wall Street analysts that have issued a 1 year NSTG price target, the average NSTG price target is $21.20, with the highest NSTG stock price forecast at $37.00 and the lowest NSTG stock price forecast at $14.00.

On average, Wall Street analysts predict that Nanostring Technologies's share price could reach $21.20 by Mar 2, 2024. The average Nanostring Technologies stock price prediction forecasts a potential upside of 145.09% from the current NSTG share price of $8.65.

What is NSTG's Earnings Per Share (EPS) forecast for 2023-2024?

(NASDAQ: NSTG) Nanostring Technologies's current Earnings Per Share (EPS) is -$3.44. On average, analysts forecast that NSTG's EPS will be -$1.92 for 2023, with the lowest EPS forecast at -$2.05, and the highest EPS forecast at -$1.82. In 2024, NSTG's EPS is forecast to hit -$1.29 (min: -$1.29, max: -$1.29).

What is NSTG's forecast return on equity (ROE) for 2023-2024?

(NASDAQ: NSTG) forecast ROE is -131.75%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.